Rise Therapeutics, a clinical-stage immunotherapy company headquartered in Rockville’s Biotech Corridor, was among 13 Maryland companies to receive funding through TEDCO’s latest SBIR/STTR Matching Funds awards. The program distributed $875,000 across two rounds, with 11 companies, including Rise Therapeutics who received $75,000 in Phase II matching funds.

The SBIR/STTR Matching Funds program strengthens the impact of federal Small Business Innovation Research and Small Business Technology Transfer awards by providing supplemental state funding to promote commercialization and job creation.

Rise Therapeutics is developing first-in-class oral immune biomodulators for the treatment of autoimmune diseases and cancer. Unlike traditional biological therapies requiring injection or infusion, the company’s proprietary platform delivers targeted protein therapy through oral capsules. Rise currently has four programs in clinical testing, including therapies for ulcerative colitis, rheumatoid arthritis, Sjögren’s disease, and cancer.

The company operates a GMP manufacturing facility in Rockville and has previously received TEDCO Seed Funds investment as well as NIH funding to support its clinical development.

Learn more about TEDCO’s SBIR/STTR Matching Funds program at tedcomd.com/funding/federal-programs/sbirsttr-matching-funds

About Rise Therapeutics

Rise Therapeutics is a clinical-stage immunotherapy company developing first-in-class Oral Immune Biomodulators, for the treatment of autoimmune diseases and cancer. With a fully integrated research and product development infrastructure, the team leverages innovative scientific discoveries to drive novel drug development through human clinical proof-of-concept. Learn more at risetherapeutics.com

About TEDCO

TEDCO, the Maryland Technology Development Corporation, enhances economic empowerment growth through the fostering of an inclusive entrepreneurial innovation ecosystem. TEDCO identifies, invests in, and helps grow technology and life science-based companies in Maryland. Learn more at www.tedcomd.com